COL11A1/(pro)collagen 11A1 expression is a remarkable biomarker of human invasive carcinoma-associated stromal cells and carcinoma progression

Tumor Biology

Volumn 36, Issue 4, 2015, Pages 2213-2222

  Vázquez Villa, Fernando ^a,b   García Ocaña, Marcos ^a,b   Galván, José A ^a,b,d   García Martínez, Jorge ^a,b   García Pravia, Carmen ^b,c   Menéndez Rodríguez, Primitiva ^c   Rey, Carmen González del ^c   Barneo Serra, Luis ^a,b   de los Toyos, Juan R ^a,b  

^a UNIVERSITY OF OVIEDO   (Spain)

^b Oncology University Institute of the Principality of Asturias   (Spain)

^c Central University Hospital of Asturias (HUCA)   (Spain)

^d UNIVERSITY OF BERN   (Switzerland)

Author keywords

(Pro)collagen 11A1; COL11A1; Human invasive carcinoma; Stromal cells

Indexed keywords

COL11A1 PROTEIN, HUMAN; COLLAGEN TYPE 11; TRANSFORMING GROWTH FACTOR BETA1;

BIOSYNTHESIS; CARCINOGENESIS; CARCINOMA; GENE EXPRESSION REGULATION; GENETICS; HUMAN; NEOPLASM; PATHOLOGY; TUMOR INVASION;

CARCINOGENESIS; CARCINOMA; COLLAGEN TYPE XI; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM INVASIVENESS; NEOPLASMS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84936757299     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-015-3295-4     Document Type: Review

References (97)

1. Fan D, Takawale A, Lee J, Kassiri Z. Cardiac fibroblasts, fibrosis and extracellular matrix remodeling in heart disease. Fibrogenesis Tissue Repair. 2012;5:15. doi:10.1186/1755-1536-5-15.
2. Canty EG, Kadler KE. Procollagen trafficking, processing and fibrillogenesis. J Cell Sci. 2005;118:1341–53.
3. Kadler KE, Hill A, Canty-Laird EG. Collagen fibrillogenesis: fibronectin, integrins, and minor collagens as organizers and nucleators. Curr Opin Cell Biol. 2008;20:495–501.
4. GeneCards: http://www.genecards.org/cgi-bin/carddisp.pl?gene=COL11A1&search=60c7972800f65b34c22171d38f22a63f. Accessed 23 Dec 2014.
5. Kao L-P, Yu S-L, Singh S, Wang K-H, Kao A-P, Li SS. Comparative profiling of mRNA and microRNA expression in human mesenchymal stem cells derived from adult adipose and lipoma tissues. Open Stem Cell J. 2009;1:1–9. doi:10.2174/1876893800901010001.
6. Grundberg E, Brändström H, Lam KC, Gurd S, Ge B, Harmsen E, et al. Systematic assessment of the human osteoblast transcriptome in resting and induced primary cells. Physiol Genomics. 2008;33:301–11.
7. Matsuo N, Yu-Hua W, Sumiyoshi H, Sakata-Takatani K, Nagato H, Sakai K, et al. The transcription factor CCAAT-binding factor CBF/NF-Y regulates the proximal promoter activity in the human alpha 1(XI) collagen gene (COL11A1). J Biol Chem. 2003;278:32763–70.
8. Hida M, Hamanaka R, Okamoto O, Yamashita K, Sasaki T, Yoshioka H, et al. Nuclear factor Y (NF-Y) regulates the proximal promoter activity of the mouse collagen α1(XI) gene (Col11a1) in chondrocytes. In Vitro Cell Dev Biol Anim. 2014;50:358–66. doi:10.1007/s11626-013-9692-3.
9. Kahler RA, Yingst SM, Hoeppner LH, Jensen ED, Krawczak D, Oxford JT, et al. Collagen 11a1 is indirectly activated by lymphocyte enhancer-binding factor 1 (Lef1) and negatively regulates osteoblast maturation. Matrix Biol. 2008;27:330–8. doi:10.1016/j.matbio.2008.01.002.
10. Emura M, Ochiai A, Horino M, Arndt W, Kamino K, Hirohashi S. Development of myofibroblasts from human bone marrow mesenchymal stem cells cocultured with human colon carcinoma cells and TGF beta 1. In Vitro Cell Dev Biol Anim. 2000;36:77–80.
11. Karnoub AE, Dash AB, Vo AP, Sullivan A, Brooks MW, Bell GW, et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature. 2007;449:557–63.
12. Mishra PJ, Mishra PJ, Humeniuk R, Medina DJ, Alexe G, Mesirov JP, et al. Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells. Cancer Res. 2008;68:4331–9. doi:10.1158/0008-5472.CAN-08-0943.
13. Gardner H, Strehlow D, Bradley L, Widom R, Farina A, de Fougerolles A, et al. Global expression analysis of the fibroblast transcriptional response to TGFbeta. Clin Exp Rheumatol. 2004;22(3 Suppl 33):S47–57.
14. Wu YH, Chang TH, Huang YF, Huang HD, Chou CY. COL11A1 promotes tumor progression and predicts poor clinical outcome in ovarian cancer. Oncogene. 2014;33:3432–40. doi:10.1038/onc.2013.307.
15. Oliveira FS, Bellesini LS, Defino HL, da Silva Herrero CF, Beloti MM, Rosa AL. Hedgehog signaling and osteoblast gene expression are regulated by purmorphamine in human mesenchymal stem cells. J Cell Biochem. 2012;113:204–8. doi:10.1002/jcb.23345.
16. Kojima Y, Acar A, Eaton EN, Mellody KT, Scheel C, Ben-Porath I, et al. Autocrine TGF-beta and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts. Proc Natl Acad Sci U S A. 2010;107:20009–14. doi:10.1073/pnas.1013805107.
17. Mishra P, Banerjee D, Ben-Baruch A. Chemokines at the crossroads of tumor-fibroblast interactions that promote malignancy. J Leukoc Biol. 2011;89:31–9. doi:10.1189/jlb.0310182.
18. Margolin DA, Silinsky J, Grimes C, Spencer N, Aycock M, Green H, et al. Lymph node stromal cells enhance drug-resistant colon cancer cell tumor formation through SDF-1α/CXCR4 paracrine signaling. Neoplasia. 2011;13:874–86.
19. Polanska UM, Orimo A. Carcinoma-associated fibroblasts: non-neoplastic tumour-promoting mesenchymal cells. J Cell Physiol. 2013;228:1651–7. doi:10.1002/jcp.24347.
20. Fischer H, Salahshor S, Stenling R, Björk J, Lindmark G, Iselius L, Rubio C, Lindblom A. COL11A1 in FAP polyps and in sporadic colorectal tumors. BMC Cancer 2001;1:17. http://www.biomedcentral.com/1471-2407/1/17.
21. Pilarsky C, Ammerpohl O, Sipos B, Dahl E, Hartmann A, Wellmann A, et al. Activation of Wnt signalling in stroma from pancreatic cancer identified by gene expression profiling. J Cell Mol Med. 2008;12:2823–35.
22. Bailey JM, Swanson BJ, Hamada T, Eggers JP, Singh PK, Caffery T, et al. Sonic hedgehog promotes desmoplasia in pancreatic cancer. Clin Cancer Res. 2008;14:5995–6004. doi:10.1158/1078-0432.CCR-08-0291.
23. Tian H, Callahan CA, DuPree KJ, Darbonne WC, Ahn CP, Scales SJ, et al. Hedgehog signaling is restricted to the stromal compartment during pancreatic carcinogenesis. Proc Natl Acad Sci U S A. 2009;106:4254–9. doi:10.1073/pnas.0813203106.
24. Gene Expression Atlas- Summary for COL11A1 (Homo sapiens). http://www-test.ebi.ac.uk/gxa/gene/ENSG00000060718. Accessed 23 Dec 2014.
25. Lin PP, Wang Y, Lozano G. Mesenchymal stem cells and the origin of Ewing’s sarcoma. Sarcoma. 2011;pii:276463. doi: 10.1155/2011/276463.
26. Hajdu M, Singer S, Maki RG, Schwartz GK, Keohan ML, Antonescu CR. IGF2 over-expression in solitary fibrous tumours is independent of anatomical location and is related to loss of imprinting. J Pathol. 2010;221:300–7.
27. An JH, Lee SY, Jeon JY, Cho KG, Kim SU, Lee MA. Identification of gliotropic factors that induce human stem cell migration to malignant tumor. J Proteome Res. 2009;8:2873–81.
28. Chernov AV, Baranovskaya S, Golubkov VS, Wakeman DR, Snyder EY, Williams R, et al. Microarray-based transcriptional and epigenetic profiling of matrix metalloproteinases, collagens, and related genes in cancer. J Biol Chem. 2010;285:19647–59.
29. Pope WB, Mirsadraei L, Lai A, Eskin A, Qiao J, Kim HJ, et al. Differential gene expression in glioblastoma defined by ADC histogram analysis: relationship to extracellular matrix molecules and survival. AJNR Am J Neuroradiol. 2012;33:1059–64. doi:10.3174/ajnr.A2917.
30. Seemann L, Shulman J, Gunaratne GH. A robust topology-based algorithm for gene expression profiling. ISRN Bioinformatics 2012; Article ID 381023. doi:10.5402/2012/381023.
31. Chen W, Fu X, Sun X, Sun T, Zhao Z, Sheng Z. Analysis of differentially expressed genes in keloids and normal skin with cDNA microarray. J Surg Res. 2003;113:208–16.
32. Seifert O, Bayat A, Geffers R, Dienus K, Buer J, Löfgren S, et al. Identification of unique gene expression patterns within different lesional sites of keloids. Wound Repair Regen. 2008;16:254–65. doi:10.1111/j.1524-475X.2007.00343.x.
33. Yagi Y, Muroga E, Naitoh M, Isogai Z, Matsui S, Ikehara S, et al. An ex vivo model employing keloid-derived cell-seeded collagen sponges for therapy development. J Investig Dermatol. 2013;133:386–93. doi:10.1038/jid.2012.314.
34. Gardner H, Shearstone JR, Bandaru R, Crowell T, Lynes M, Trojanowska M, et al. Gene profiling of scleroderma skin reveals robust signatures of disease that are imperfectly reflected in the transcript profiles of explanted fibroblasts. Arthritis Rheum. 2006;54:1961–73.
35. Togo S, Polanska UM, Horimoto Y, Orimo A. Carcinoma-associated fibroblasts are a promising therapeutic target. Cancers (Basel). 2013;5:149–69. doi:10.3390/cancers5010149.
36. Midwood KS, Orend G. The role of tenascin-C in tissue injury and tumorigenesis. J Cell Commun Signal. 2009;3:287–310. doi:10.1007/s12079-009-0075-1.
37. Sidhu SS, Yuan S, Innes AL, Kerr S, Woodruff PG, Hou L, et al. Roles of epithelial cell-derived periostin in TGF-beta activation, collagen production, and collagen gel elasticity in asthma. Proc Natl Acad Sci U S A. 2010;107:14170–5. doi:10.1073/pnas.1009426107.
38. Mifflin RC, Pinchuk IV, Saada JI, Powell DW. Intestinal myofibroblasts: targets for stem cell therapy. Am J Physiol Gastrointest Liver Physiol. 2011;300:G684–96. doi:10.1152/ajpgi.00474.2010.
39. Nishioka Y, Azuma M, Kishi M, Aono Y. Targeting platelet-derived growth factor as a therapeutic approach in pulmonary fibrosis. J Med Invest. 2013;60:175–83.
40. Keane FM, Yao TW, Seelk S, Gall MG, Chowdhury S, Poplawski SE, et al. Quantitation of fibroblast activation protein (FAP)-specific protease activity in mouse, baboon and human fluids and organs. FEBS Open Bio. 2013;4:43–54. doi:10.1016/j.fob.2013.12.001.
41. Rönty M. Palladin, a novel microfilament protein. PhD thesis. University of Helsinki, Department of Pathology; 2008.
42. Schacht V, Dadras SS, Johnson LA, Jackson DG, Hong YK, Detmar M. Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors. Am J Pathol. 2005;166:913–21.
43. Fuentes-Martínez N, García-Pravia C, García-Ocaña M, Menéndez-Rodríguez P, Del Amo J, Suárez-Fernández L, et al. Overexpression of proCOL11A1 as a stromal marker of breast cancer. Histol Histopathol. 2015;30:87–93.
44. Erkan M, Weis N, Pan Z, Schwager C, Samkharadze T, Jiang X, et al. Organ-, inflammation- and cancer specific transcriptional fingerprints of pancreatic and hepatic stellate cells. Mol Cancer 2010;9:88. http://www.molecular-cancer.com/content/9/1/88.
45. Prenzel KL, Ribati M, Warnecke-Ebers U, Stöcklein N, Vallböhmer D, Stippel D, et al. Differential expression of COL11A1 in chronic pancreatitis and periampullary adenocarcinomas. Deut Ges Chir. 2009;38:209–10. Chirurgisches Forum und DGAV Forum 2009.
46. Dooley TP, Curto EV, Reddy SP, Davis RL, Lambert GW, Wilborn TW, et al. Regulation of gene expression in inflammatory bowel disease and correlation with IBD drugs: screening by DNA microarrays. Inflamm Bowel Dis. 2004;10:1–14.
47. Fang M, Yuan J, Peng C, Li Y. Collagen as a double-edged sword in tumor progression. Tumor Biol. 2014;35:2871–82. doi:10.1007/s13277-013-1511-7.
48. Schmalbach CE, Chepeha DB, Giordano TJ, Rubin MA, Teknos TN, Bradford CR, et al. Molecular profiling and the identification of genes associated with metastatic oral cavity/pharynx squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 2004;130:295–302.
49. Sok JC, Kuriakose MA, Mahajan VB, Pearlman AN, DeLacure MD, Chen FA. Tissue-specific gene expression of head and neck squamous cell carcinoma in vivo by complementary DNA microarray analysis. Arch Otolaryngol Head Neck Surg. 2003;129:760–70.
50. Sok JC, Lee JA, Dasari S, Joyce S, Contrucci SC, Egloff AM, et al. Collagen type XI α1 facilitates head and neck squamous cell cancer growth and invasion. Br J Cancer. 2013;109:3049–56. doi:10.1038/bjc.2013.624.
51. Fuentes-Martínez N. Colágeno 11: nuevo marcador en el cáncer de mama. PhD thesis. Universidad de Oviedo, Surgery and Medical Surgical Specialities Department; 2009.
52. Pavlides S, Tsirigos A, Vera I, Flomenberg N, Frank PG, Casimiro MC, et al. Transcriptional evidence for the “reverse Warburg effect” in human breast cancer tumor stroma and metastasis: similarities with oxidative stress, inflammation, Alzheimer’s disease, and “neuron-glia metabolic coupling”. Aging (Albany NY). 2010;2:185–99.
53. Planche A, Bacac M, Provero P, Fusco C, Delorenzi M, Stehle JC, et al. Identification of prognostic molecular features in the reactive stroma of human breast and prostate cancer. PLoS ONE. 2011;6:e18640. doi:10.1371/journal.pone.0018640.
54. García-Ocaña M, Vázquez F, García-Pravia C, Fuentes-Martínez N, Menéndez-Rodríguez P, Fresno-Forcelledo F, et al. Characterization of a novel mouse monoclonal antibody, clone 1E8.33, highly specific for human procollagen 11A1, a tumor-associated stromal component. Int J Oncol. 2012;40:1447–54. doi:10.3892/ijo.2012.1360.
55. Freire J, Domínguez-Hormaetxe S, Pereda S, De Juan A, Vega A, Simón L, Gómez-Román J. Collagen, type XI, alpha 1: an accurate marker for differential diagnosis of breast carcinoma invasiveness in core needle biopsies. Pathol Res Pract. 2014; pii: S0344-0338(14)00225-8. doi: 10.1016/j.prp.2014.07.012.
56. Wang KK, Liu N, Radulovich N, Wigle DA, Johnston MR, Shepherd FA, et al. Novel candidate tumor marker genes for lung adenocarcinoma. Oncogene. 2002;21:7598–604.
57. Chong IW, Chang MY, Chang HC, Yu YP, Sheu CC, Tsai JR, et al. Great potential of a panel of multiple hMTH1, SPD, ITGA11 and COL11A1 markers for diagnosis of patients with non-small cell lung cancer. Oncol Rep. 2006;16:981–8.
58. Fuentes N, Pravia CG, Rodriguez PM, Toyos JR D l, Ocana MG, Del Amo J, et al. Anticol11a1 a marker of infiltration in bronchioloalveolar lung carcinoma. Virchows Arch. 2010;457:230.
59. Sun Y, Wang L, Jiang M, Huang J, Liu Z, Wolfl S. Secreted phosphoprotein 1 upstream invasive network construction and analysis of lung adenocarcinoma compared with human normal adjacent tissues by integrative biocomputation. Cell Biochem Biophys. 2010;56:59–71. doi:10.1007/s12013-009-9071-6.
60. Navab R, Strumpf D, Bandarchi B, Zhu CQ, Pintilie M, Ramnarine VR, et al. Prognostic gene-expression signature of carcinoma-associated fibroblasts in non-small cell lung cancer. Proc Natl Acad Sci U S A. 2011;108:7160–5. doi:10.1073/pnas.1014506108.
61. Xu SH, Qian LJ, Mou HZ, Zhu CH, Zhou XM, Liu XL, et al. Difference of gene expression profiles between esophageal carcinoma and its pericancerous epithelium by gene chip. World J Gastroenterol. 2003;9:417–22.
62. Vecchi M, Nuciforo P, Romagnoli S, Confalonieri S, Pellegrini C, Serio G, et al. Gene expression of early and advanced gastric cancer. Oncogene. 2007;26:4284–94.
63. Zhao Y, Zhou T, Li A, Yao H, He F, Wang L, et al. A potential role of collagens expression in distinguishing between premalignant and malignant lesions in stomach. Anat Rec. 2009;292:692–700.
64. Barneo L, del Amo J, García-Pravia C, Toyos JR D l, Pérez-Basterrechea M, González-Pinto I, et al. Identification of specific genes by microarrays, validation and use of polyclonal antibodies in pancreatic cancer: preliminary results. In: Vollmar B, editor. 41st congress of the European society for surgical research-ESSR 2006. Bologna: Medimond, International Proceedings; 2006. p. 27–35.
65. del Amo-Iribarren J. Identificación de marcadores para diagnóstico diferencial y potenciales dianas terapéuticas en adenocarcinoma ductal de páncreas mediante herramientas genómicas. PhD thesis. Universidad del País Vasco, Genetics, Physical Anthropology and Animal Physiology Department; 2006.
66. García-Pravia C, Galván JA, Gutiérrez-Corral N, Solar-García L, García-Pérez E, García-Ocaña M, et al. Overexpression of COL11A1 by cancer-associated fibroblasts: clinical relevance of a stromal marker in pancreatic cancer. PLoS ONE. 2013;8:e78327. doi:10.1371/journal.pone.0078327.
67. Fischer H, Stenling R, Rubio C, Lindblom A. Colorectal carcinogenesis is associated with stromal expression of COL11A1 and COL5A2. Carcinogenesis. 2001;22:875–8. doi:10.1093/carcin/22.6.875.
68. Croner RS, Foertsch T, Brueckl WM, Guenther K, Siebenhaar R, Stremmel C, et al. Common denominator genes that distinguish colorectal carcinoma from normal mucosa. Int J Color Dis. 2005;20:353–62.
69. Lascorz J, Hemminki K, Försti A. Systematic enrichment analysis of gene expression profiling studies identifies consensus pathways implicated in colorectal cancer development. J Carcinog. 2011;10:7. doi:10.4103/1477-3163.78268.
70. Cueva-Cayetano R, Galvan-Hernandez JÁ, Suarez-Fernandez L, Menendez-Rodriguez MP, Garcia-Pravia C, Barneo L. Preliminary analysis of collagen, type XI, alpha 1 (COL11A1), inhibin alpha (INHBA) and secreted protein acidic and rich in cysteine (SPARC, osteonectin) as potential markers of colon cancer [abstract]. Brit J Surg. 2013;100 Suppl 1:7.
71. Galván JA, García-Martínez J, Vázquez-Villa F, García-Ocaña M, García-Pravia C, Menéndez-Rodríguez P, et al. Validation of COL11A1/procollagen 11A1 expression in TGF-β1-activated immortalised human mesenchymal cells and in stromal cells of human colon adenocarcinoma. BMC Cancer. 2014;14:867. doi:10.1186/1471-2407-14-867.
72. Cheon DJ, Tong Y, Sim MS, Dering J, Berel D, Cui X, et al. A collagen-remodeling gene signature regulated by TGF-β signaling is associated with metastasis and poor survival in serous ovarian cancer. Clin Cancer Res. 2014;20:711–23. doi:10.1158/1078-0432.CCR-13-1256.
73. Schuetz CS, Bonin M, Clare SE, Nieselt K, Sotlar K, Walter M, et al. Progression-specific genes identified by expression profiling of matched ductal carcinomas in situ and invasive breast tumors, combining laser capture microdissection and oligonucleotide microarray analysis. Cancer Res. 2006;66:5278–86.
74. Ma XJ, Dahiya S, Richardson E, Erlander M, Sgroi DC. Gene expression profiling of the tumor microenvironment during breast cancer progression. Breast Cancer Res. 2009;11:R7. doi:10.1186/bcr2222.
75. Lee S, Stewart S, Nagtegaal I, Luo J, Wu Y, Colditz G, et al. Differentially expressed genes regulating the progression of ductal carcinoma in situ to invasive breast cancer. Cancer Res. 2012;72:4574–86. doi:10.1158/0008-5472.CAN-12-0636.
76. Castellana B, Escuin D, Peiró G, Garcia-Valdecasas B, Vázquez T, Pons C, et al. ASPN and GJB2 are implicated in the mechanisms of invasion of ductal breast carcinomas. J Cancer. 2012;3:175–83. doi:10.7150/jca.4120.
77. Vargas AC, McCart Reed AE, Waddell N, Lane A, Reid LE, Smart CE, et al. Gene expression profiling of tumour epithelial and stromal compartments during breast cancer progression. Breast Cancer Res Treat. 2012;135:153–65. doi:10.1007/s10549-012-2123-4.
78. Zhu TX, Lan B, Meng LY, Yang YL, Li RX, Li EM, et al. ECM-related gene expression profile in vascular smooth muscle cells from human saphenous vein and internal thoracic artery. J Cardiothorac Surg. 2013;8:155. doi:10.1186/1749-8090-8-155.
79. Buckanovich RJ, Sasaroli D, O’Brien-Jenkins A, Botbyl J, Hammond R, Katsaros D, et al. Tumor vascular proteins as biomarkers in ovarian cancer. J Clin Oncol. 2007;25:852–61.
80. Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest. 2009;119:1420–8. doi:10.1172/JCI39104.
81. Zeisberg M, Neilson EG. Biomarkers for epithelial-mesenchymal transitions. J Clin Invest. 2009;119:1429–37. doi:10.1172/JCI36183.
82. Moreno-Bueno G, Peinado H, Molina P, Olmeda D, Cubillo E, Santos V, et al. The morphological and molecular features of the epithelial-to-mesenchymal transition. Nat Protoc. 2009;4:1591–613.
83. Badea L, Herlea V, Dima SO, Dumitrascu T, Popescu I. Combined gene expression analysis of whole-tissue and microdissected pancreatic ductal adenocarcinoma identifies genes specifically overexpressed in tumor epithelia. Hepatogastroenterology. 2008;55:2016–27.
84. Anastassiou D, Rumjantseva V, Cheng W, Huang J, Canoll PD, Yamashiro DJ, Kandel JJ. Human cancer cells express Slug-based epithelial-mesenchymal transition gene expression signature obtained in vivo. BMC Cancer 2011; 11:529. http://www.biomedcentral.com/1471-2407/11/529.
85. Xu Z, Vonlaufen A, Phillips PA, Fiala-Beer E, Zhang X, Yang L, et al. Role of pancreatic stellate cells in pancreatic cancer metastasis. Am J Pathol. 2010;177:2585–96. doi:10.2353/ajpath.2010.090899.
86. Pishvaian MJ, Feltes CM, Thompson P, Bussemakers MJ, Schalken JA, Byers SW. Cadherin-11 is expressed in invasive breast cancer cell lines. Cancer Res. 1999;59:947–52.
87. Chu K, Cheng CJ, Ye X, Lee YC, Zurita AJ, Chen DT, et al. Cadherin-11 promotes the metastasis of prostate cancer cells to bone. Mol Cancer Res. 2008;6:1259–67.
88. Huang CF, Lira C, Chu K, Bilen MA, Lee YC, Ye X, et al. Cadherin-11 increases migration and invasion of prostate cancer cells and enhances their interaction with osteoblasts. Cancer Res. 2010;70:4580–9.
89. Armstrong AJ, Marengo MS, Oltean S, Kemeny G, Bitting RL, Turnbull JD, et al. Circulating tumor cells from patients with advanced prostate and breast cancer display both epithelial and mesenchymal markers. Mol Cancer Res. 2011;9:997–1007.
90. Kim H, Watkinson J, Varadan V, Anastassiou D. Multi-cancer computational analysis reveals invasion-associated variant of desmoplastic reaction involving INHBA, THBS2 and COL11A1. BMC Med Genomics 2010;3:51. http://www.biomedcentral.com/1755-8794/3/51.
91. Suzuki M, Tarin D. Gene expression profiling of human lymph node metastases and matched primary breast carcinomas: clinical implications. Mol Oncol. 2007;1:172–80. doi:10.1016/j.molonc.2007.03.005.
92. Feng Y, Sun B, Li X, Zhang L, Niu Y, Xiao C, et al. Differentially expressed genes between primary cancer and paired lymph node metastases predict clinical outcome of node-positive breast cancer patients. Breast Cancer Res Treat. 2007;103:319–29.
93. Ellsworth RE, Seebach J, Field LA, Heckman C, Kane J, Hooke JA, et al. A gene expression signature that defines breast cancer metastases. Clin Exp Metastasis. 2009;26:205–13. doi:10.1007/s10585-008-9232-9.
94. Yuzugullu H, Benhaj K, Ozturk N, Senturk S, Celik E, Toylu A, et al. Canonical Wnt signaling is antagonized by noncanonical Wnt5a in hepatocellular carcinoma cells. Mol Cancer. 2009;8:90. doi:10.1186/1476-4598-8-90.
95. López-Lago MA, Thodima VJ, Guttapalli A, Chan T, Heguy A, Molina AM, et al. Genomic deregulation during metastasis of renal cell carcinoma implements a myofibroblast-like program of gene expression. Cancer Res. 2010;70:9682–92. doi:10.1158/0008-5472.CAN-10-2279.
96. ArrayExpress Experiment E-MTAB-37. Transcription profiling of human multiple cancer cell lines (950 samples). http://www-test.ebi.ac.uk/gxa/experiment/E-MTAB-37/ENSG00000060718?ef=cell_line. Accessed 23 Dec 2014.
97. Raglow Z, Thomas SM. Tumor matrix protein collagen XIα1 in cancer. Cancer Lett. 2015;357:448–53. doi:10.1016/j.canlet.2014.12.011.